Menu
Home
About Us
Who We Are
Purpose & Values
Board
Partners
Distributors
Compliance
Careers
Technology
Our Solution
Technology Introduction
Platform Technology
Publications
Image Gallery
Webinars
FAQ
Products
Our Products
InVivage
ViewnVivo
Customisation
Pipeline
Investor
Investor Overview
ASX Announcements
Reports
Share Price Information
Financial Calendar
Media Coverage
Sustainability
Share Registry
Investor Alerts
Media
News
Social Media Feed
Contact
Contact
Select Category
Clinical Research
Oral cancer diagnosis and surgical margin
Brain cancer
General surgery
Cervical assessment
Gastrointestinal assessment
Life Sciences Research
Cell viability
Live antibody labelling
Intraoperative surgery and tumour margin delineation
Blood vessel, perfusion, and barrier function
Live microflora imaging
Nano particle and drug delivery
Proof of concept in live models
Recent Posts
Optiscan in the news: Optiscan advances medical manufacturing with telepathology platform beta test
Optiscan in the news: Aussie made: ASX firms boosting local health & medical manufacturing
Optiscan in the news: Optiscan Imaging to transform digital pathology
Optiscan in the news: Optiscan Imaging completes beta phase testing of cloud-based telepathology platform
Optiscan in the news: Optiscan reveals new breakthrough on remote pathology technology
Archives
July 2024
June 2024
May 2024
April 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
November 2022
September 2022
February 2022
May 2021
Categories
Announcements
Blood vessel, perfusion, and barrier function
Brain cancer
Broker Research
Cell viability
Cervical assessment
Gastrointestinal assessment
General surgery
Intraoperative surgery and tumour margin delineation
Live antibody labelling
Live microflora imaging
Nano particle and drug delivery
Optiscan news
Oral cancer diagnosis and surgical margin
Proof of concept in live models
Uncategorized
Veterinary
Two new clinical publications for CONVIVO in brain cancer
January 12th, 2021 by Optiscan
Read More
Optiscan’s Melbourne Dental School Study Featured in Melbourne’s Herald Sun
December 18th, 2020 by Optiscan
Read More
Melbourne Dental School and Optiscan’s Oral Cancer Screening Study discussed in Bite magazine – leading business magazine for dental professionals
December 17th, 2020 by Optiscan
Read More
Appointment of J&H Technology Co Ltd as Optiscan’s exclusive pre-clinical distributor for Taiwan
December 16th, 2020 by Optiscan
Read More
1
2
3
Back to All Publications
